0.2875
price down icon0.86%   -0.0025
after-market After Hours: .28 -0.0075 -2.61%
loading

Hepion Pharmaceuticals Inc Stock (HEPA) Forecast

The Hepion Pharmaceuticals Inc (HEPA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $10.19, representing a +3,445% increase from the current price of $0.2875. The highest analyst price target is $19.59, and the lowest is $0.7905.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HEPA Price Target
Average 26.12 (+8,987% Upside)
loading

Is Hepion Pharmaceuticals Inc (HEPA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 21.08 Buy
STOCH(9,6) 8.4882 Buy
STOCHRSI(14) 46.45 Neutral
MACD(12,26) -0.7169 Buy
ADX(14) 25.00 Sell
William %R -92.45 Buy
CCI(14) -45.95 Neutral
Buy: 4 Sell: 1 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
0.3234
Sell
0.3369
Sell
MA20
0.391
Sell
0.6697
Sell
MA50
2.8764
Sell
3.8712
Sell
MA100
12.06
Sell
11.26
Sell
MA200
24.06
Sell
29.60
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, HEPA could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on HEPA, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 21.08 indicates that HEPA is oversold. This indicates that HEPA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 8.4882 indicates that HEPA is oversold. This indicates that HEPA price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.45 indicates that HEPA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 25 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -45.95 indicates that HEPA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term HEPA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Hepion Pharmaceuticals Inc financial reports and earnings history, Hepion Pharmaceuticals Inc (HEPA) stock could reach $56.58 by 2030, $18.04 by 2040 and $64.65 by 2050. See the projected annual prices until 2050 of the Hepion Pharmaceuticals Inc stock below:

  • Hepion Pharmaceuticals Inc (HEPA) is expected to reach an average price of $2.499 in 2035, with a high prediction of $3.7602 and a low estimate of $2.799. This indicates an $769.21% rise from the last recorded price of $0.2875.
  • Hepion Pharmaceuticals Inc (HEPA) stock is projected to chart a bullish course in 2040, with an average price target of $18.03, representing an $6,172% surge from its current level. The forecast ranges from a conservative $18.13 to a sky-high $18.04.
  • Our analysts predict Hepion Pharmaceuticals Inc (HEPA) to jump 12,364% by 2045, soaring from $35.78 to an average price of $35.83, potentially reaching $35.94. While $35.78 is the low estimate, the potential upside is significant.
  • Hepion Pharmaceuticals Inc (HEPA) stock is expected to climb by 2050, reaching an average of $62.20, a $21,533% jump from its current level. However, a wide range of estimates exists, with high and low targets of $64.65 and $62.50, respectively, highlighting the market's uncertainty.

Hepion Pharmaceuticals Inc Stock (HEPA) Year by Year Forecast

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2025

Hepion Pharmaceuticals Inc Stock (HEPA) is expected to reach an average price of $27.37 in 2025, with a high prediction of $54.05 and a low estimate of $0.69. This indicates an +9,421% rise from the last recorded price of $0.2875.
Month Average Low High Change from today's price
May, 2025 $10.69 $0.7905 $19.59 +3,617%
June, 2025 $34.97 $8.9842 $49.98 +12,065%
July, 2025 $19.56 $18.56 $51.57 +6,703%
August, 2025 $24.35 $15.06 $33.35 +8,368%
September, 2025 $22.73 $10.94 $24.13 +7,807%
October, 2025 $17.12 $10.12 $31.33 +5,854%
November, 2025 $9.2943 $9.0911 $18.92 +3,133%
December, 2025 $4.29 $0.69 $14.49 +1,392%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2026

The predicted value for Hepion Pharmaceuticals Inc (HEPA) in 2026 is set at an average of $12.58. Estimates vary from a peak of $24.47 to a trough of $0.6806, indicating an +4,275% surge from the present price of $0.2875.
Month Average Low High Change from today's price
January, 2026 $6.2775 $0.6806 $9.2775 +2,083%
February, 2026 $1.3351 $2.1319 $24.47 +364.37%
March, 2026 $0.9476 $1.4845 $11.46 +229.61%
April, 2026 $2.1633 $0.7508 $3.0492 +652.46%
May, 2026 $1.9759 $4.8759 $3.1476 +587.26%
June, 2026 $10.01 $1.0599 $11.18 +3,382%
July, 2026 $2.4041 $2.4022 $10.41 +736.22%
August, 2026 $4.8167 $4.3073 $3.8187 +1,575%
September, 2026 $0.6324 $1.6261 $4.3708 +119.96%
October, 2026 $2.2449 $1.8418 $1.3614 +680.84%
November, 2026 $0.8575 $1.6512 $1.0543 +198.26%
December, 2026 $6.0732 $2.2606 $3.758 +2,012%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Hepion Pharmaceuticals Inc (HEPA) is $6.3105, with a high forecast of $10.89 and a low forecast of $1.736. This indicates an +2,095% increase from the last price of $0.2875.
Month Average Low High Change from today's price
January, 2027 $6.2857 $5.6826 $4.2795 +2,086%
February, 2027 $9.6103 $5.8889 $7.3983 +3,243%
March, 2027 $6.714 $7.5108 $7.7046 +2,235%
April, 2027 $4.5265 $4.9234 $4.9171 +1,474%
May, 2027 $3.5391 $1.736 $1.3391 +1,131%
June, 2027 $10.90 $4.9422 $7.2148 +3,691%
July, 2027 $8.8253 $9.1642 $8.9579 +2,970%
August, 2027 $11.73 $10.16 $9.1819 +3,980%
September, 2027 $11.40 $10.75 $10.89 +3,864%
October, 2027 $8.6042 $8.629 $9.1207 +2,893%
November, 2027 $8.8227 $8.6504 $7.8176 +2,969%
December, 2027 $9.7724 $10.36 $9.6364 +3,299%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2028

In 2028, Hepion Pharmaceuticals Inc (HEPA) is projected to reach an average price of $5.5258, with a high projection of $10.92 and a low estimate of $0.1274. This indicates an +1,822% rise from the last price of $0.2875.
Month Average Low High Change from today's price
January, 2028 $11.25 $8.9607 $9.429 +3,813%
February, 2028 $10.46 $10.86 $10.26 +3,537%
March, 2028 $7.6372 $10.75 $10.92 +2,556%
April, 2028 $1.6938 $2.3898 $7.1705 +489.14%
May, 2028 $2.1645 $0.3008 $2.654 +652.88%
June, 2028 $1.022 $0.1334 $2.4883 +255.48%
July, 2028 $0.6634 $0.1274 $2.2694 +130.76%
August, 2028 $1.9463 $0.1937 $7.9137 +576.96%
September, 2028 $0.2788 $1.6088 $1.3825 -3.02%
October, 2028 $1.1814 $0.492 $1.118 +310.91%
November, 2028 $2.9771 $1.9545 $2.4558 +935.50%
December, 2028 $2.0296 $2.2132 $2.7392 +605.96%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2029

The 2029 price forecast for Hepion Pharmaceuticals Inc Stock (HEPA) is $30.81 on average, with a high prediction of $61.50 and a low estimate of $0.1158. This represents an +10,616% increase from the previous price of $0.2875.
Month Average Low High Change from today's price
January, 2029 $3.8153 $3.4328 $3.4763 +1,227%
February, 2029 $2.9579 $3.0159 $3.0316 +928.83%
March, 2029 $3.7004 $3.271 $3.4773 +1,187%
April, 2029 $2.073 $2.883 $3.2636 +621.04%
May, 2029 $2.9387 $2.4834 $2.3087 +922.15%
June, 2029 $2.7612 $2.7912 $2.6238 +860.43%
July, 2029 $0.3238 $0.4938 $0.8375 +12.63%
August, 2029 $0.0105 $0.2895 $0.6601 -96.35%
September, 2029 $0.3571 $0.1158 $0.3193 +24.19%
October, 2029 $68.30 $0.1852 $61.50 +23,657%
November, 2029 $59.72 $64.12 $60.12 +20,674%
December, 2029 $61.55 $57.21 $59.87 +21,308%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2030

Hepion Pharmaceuticals Inc Stock (HEPA) is expected to reach an average price of $33.06 in 2030, with a high forecast of $64.16 and a low forecast of $1.9641. This signifies an +11,399% surge from the last price of $0.2875.
Month Average Low High Change from today's price
January, 2030 $45.78 $43.37 $56.58 +15,824%
February, 2030 $33.51 $45.39 $42.20 +11,555%
March, 2030 $8.8307 $3.8181 $61.19 +2,972%
April, 2030 $6.6002 $2.4558 $14.76 +2,196%
May, 2030 $2.6872 $1.9641 $36.13 +834.67%
June, 2030 $72.51 $8.2935 $49.51 +25,122%
July, 2030 $66.74 $65.93 $63.24 +23,115%
August, 2030 $62.17 $63.37 $64.16 +21,524%
September, 2030 $57.79 $58.39 $60.78 +20,002%
October, 2030 $35.53 $43.23 $45.21 +12,257%
November, 2030 $10.45 $18.05 $33.23 +3,535%
December, 2030 $12.48 $13.66 $9.7495 +4,239%
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):